InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,733.25
(
0.01%
)
US TECH 100
19,468.40
(
0.28%
)
Dow Jones
42,011.89
(
-0.47%
)
Brent Oil
73.80
(
-1.03%
)
Bitcoin
63,825.93
(
-0.69%
)
Post# of 20775
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

itwillgetbetter

Send PM Follow Ignore
Followers 0
Posts 2393
Boards Moderated 0
Alias Born 09/22/2012

itwillgetbetter

Re: None

Tuesday, 03/03/2015 12:44:38 PM

Tuesday, March 03, 2015 12:44:38 PM

Post# of 20775
Don't know exactly what this means and all (8)footnotes were removed from the Shire website however its clear Shire has classified SHP622 under the rare diseases program and many others (purple).

http://www.shire.com/shireplc/en/rd/pipeline

Under Intellect licensed programs it states OX1 may qualify for orphan drug designation.

http://www.intellectns.com/licensed-programs


Is it possible thats what they trying to decide regarding the review of data?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up